Patent ID: 8546385
Filing Date: 2013-10-01
Classification: A61P,C07D

Abstract:
1. A compound corresponding to formula (I): wherein: one of the groups A represents a nitrogen atom and the other groups A represent a carbon atom; Cy represents a phenyl or a 5- or 6-membered heteroaromatic ring; R1 represents a hydrogen atom, a halogen atom, a group (C R2 and R3 represent, independently of each other, a hydrogen atom, a halogen atom, a group (C R4 and R5 represent, independently of each other, a hydrogen atom, a halogen atom, a group (C R4 and R5 form, together with the carbon atoms to which they are attached, an ethylene group (C═CH2) or a carbonyl group (C═O); R6 represents a group —COOR9 or a group —SO R7 represents a phenyl optionally substituted with a group (C R8 represents a hydrogen atom, a group (C R9 represents a hydrogen atom or a group (C R10, R11, R12, R13 and R14 represent, independently of each other, a hydrogen atom or a group (C or a pharmaceutically acceptable salt of the compound of formula (I); with the exception of the following compounds: 2-(1-phenylsulfonyl-1H-pyrrolo[2,3-b]pyridin-2-yl-carbonyl)benzoic acid; N,N-diethyl-4-[hydroxy[1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-2-yl]methyl]-2-methoxy-3-pyridinecarboxamide; N,N-diethyl-2-methoxy-4-[[1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-2-yl]carbonyl]-3-pyridinecarboxamide; N,N-diethyl-4-[1-hydroxy-1-[1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-2-yl]ethyl]-2-methoxy-3-pyridinecarboxamide.